The first report, from Tontonoz et al., indicated that simultaneous treatment of liposarcoma cells, selected from freshly harvested tumours, with both RXRα- and PPARγ-specific ligands, synergistically stimulated differentiation. The gene discussed is PPARG; the disease is neoplasm.